Interceptor^® G2

The second generation bed net, effective against mosquitoes resistant to insecticides. Long-lasting and sustainable.

Benefits of Interceptor^® G2

Proven to be effective, even against insecticide-resistant mosquitoes
Safe and ready to use
Controls mosquitoes on contact with the net
Long-lasting performance

InterceptorÂ® G2 from BASF is the first WHO-recommended mosquito net based on non-pyrethroid chemistry to beat insecticide-resistant mosquitoes. Its distinctive black and white stripes distinguish it from currently used mosquito nets. Volker Frenz, development chemist for InterceptorÂ® G2, checks a net sample in the laboratory.
Photo â Andres/BASF
,Interceptor® G2 from BASF is the first WHO-recommended mosquito net based on non-pyrethroid chemistry to beat insecticide-resistant mosquitoes. Its distinctive black and white stripes distinguish it from currently used mosquito nets. Volker Frenz, development chemist for Interceptor® G2, checks a net sample in the laboratory.
Photo – Andres/BASF

Effective Against Resistant Mosquitoes

A combination of preventive measures is essential to eradicate malaria effectively and sustainably, including indoor residual spraying, larvicides and mosquito nets. The Interceptor^® G2 net is treated with a new generation insecticide, chlorfenapyr, and is proven to be effective against mosquitoes that are resistant to conventional insecticides, as well as being safe and easy to use.

The discovery and innovation application of chlorfenapyr is a breakthrough for BASF in the fight against malaria.

Read more about the ground-breaking research and development behind Interceptor^® G2

Loading ...

Chlorfenapyr

A new mode of action – which also works on resistant mosquitoes!

The World Health Organization

The World Health Organization (WHO) has included Interceptor^®G2 on its List of Prequalified Vector Control Products. This means that BASF can bring Interceptor^®G2 to market. A second product based on chlorfenapyr, Sylando^® 240SC, an indoor spray for walls and ceilings is currently being evaluated by the WHO.

Scientific Research Papers and Field Trial Reports on Interceptor^® G2

Product brochure

Interceptor^®G2

PDF ( 1.8 MB )

Product leaflet

Interceptor^®G2

PDF ( 465.2 kB )

BASF editorial

Malaria - Beating the threat of increasing insecticide resistance

PDF ( 2.6 MB )

Interceptor^® is not offered for sale in all countries. Please contact BASF's Public Health team for availability in your area.

Use biocides safely. Always read the label and product information before use. Observe warning phrases and symbols.

Interceptor^® is a registered trademark of BASF.

Public Health

Every year, more than one billion people suffer from mosquito-borne diseases such as malaria, dengue, chikungunya, West Nile Virus and yellow fever. Malaria alone affects over 200 million people and kills nearly 438,000 every year.

2006
Prof. Frank Hadley Collins, Dir., Cntr. for Global Health and Infectious Diseases, Univ. of Notre Dame

This 2006 photograph depicted a female <i>Aedes aegypti</i> mosquito while she was in the process of acquiring a blood meal from her human host, who in this instance, was actually the biomedical photographer, James Gathany, here at the Centers for Disease Control. You ll note the feeding apparatus consisting of a sharp, orange-colored fascicle , which while not feeding, is covered in a soft, pliant sheath called the "labellum , which retracts as the sharp stylets contained within pierce the host's skin surface, as the insect obtains its blood meal. The orange color of the fascicle is due to the red color of the blood as it migrates up the thin, sharp translucent tube.

The first reported epidemics of Dengue (DF) and dengue hemorrhagic fever (DHF) occurred in 1779-1780 in Asia, Africa, and North America. The near simultaneous occurrence of outbreaks on three continents indicates that these viruses and their mosquito vector have had a worldwide distribution in the tropics for more than 200 years. During most of this time, DF was considered a mild, nonfatal disease of visitors to the tropics. Generally, there were long intervals (10-40 years) between major epidemics, mainly because the introduction of a new serotype in a susceptible population occurred only if viruses and their mosquito vector, primarily the <i>Aedes aegypti</i> mosquito, could survive the slow transport between population centers by sailing vessels.

Mosquitoes

Successful mosquito control is best achieved by recognition and treatment of breeding sites. A regular program of inspections should be organized so that insect activity is stopped at its very source.